Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,305.00    -15.00 (-0.65%)
Bid:
2,300.00
Ask:
2,305.00
Spread: 5.00 (0.217%)
Market Cap: £3.13b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

5 Feb 2026 07:00

RNS Number : 7717R
RIT Capital Partners PLC
05 February 2026
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

5 February 2026

December 2025 Preliminary Unaudited Net Asset Value

RIT Capital Partners plc ("RIT") announces that its preliminary unaudited diluted NAV as at 31 December 2025 (with debt at fair value) was 2,921p per £1 ordinary share (30 November 2025: 2,899p). This represents a +0.8% total return for the month, outperforming the ACWI (50% £) at +0.1%.

The preliminary 31 December 2025 NAV is equivalent to a NAV per share total return for the year of +13.5%, with double-digit returns across all three investment pillars (Quoted Equities, Private Investments and Uncorrelated Strategies). Our annualised NAV per share total return since inception is +10.6%, underscoring our commitment to delivering healthy, long-term returns for our shareholders.

As is customary at this point in our year-end process, the preliminary NAV and associated performance numbers for 2025 are estimates, and subject to potential adjustment and audit. Full details will be included in the 2025 Annual Report and Accounts, which is expected to be published by early March 2026.

December 2025 Performance Highlights

RIT delivered resilient performance, demonstrating the benefits of our diversified global portfolio. Performance was led by Private Investments and Uncorrelated Strategies which contributed positively to NAV. Quoted Equities detracted modestly during the month, while the continued strengthening of sterling against the US dollar resulted in a negative translation effect on our global portfolio.

-

In Quoted Equities, weakness in technology and biotech stocks was partially offset by strong performance in our quality theme and emerging markets related holdings.

-

Private Investments delivered positive returns, helped by an uplift in December valuations of our direct holdings. As of 31 December 2025, more than 99% of our private funds were held at 30 September 2025 reported valuations and all private direct holdings were valued as at 31 December 2025, in line with our valuation policy.

-

Uncorrelated Strategies, which acts as a steady diversifier of returns, contributed positively to our NAV, supported by gold and credit.

-

We continued our share buyback programme, buying back £13.4m or approximately 593,000 shares in December, adding an estimated +9bps accretion to NAV. As at 31 December 2025, the total share capital repurchased through buybacks since the start of the year amounted to 3% at a total value of £89.0m.

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Deutsche Numis (Joint broker):

Nathan Brown, Vicki Paine

T: 020 7260 1000

 

JP Morgan Cazenove Limited (Joint broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group (Media enquiries):

Nick Cosgrove, Peter Hesse

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFBQLLLBBX
Date   Source Headline
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 202312:23 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSNet Asset Value(s)
13th Mar 202312:51 pmRNSUpdate on Silicon Valley Bank
8th Mar 20231:21 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSAnnual Financial Report
20th Feb 20237:00 amRNSNet Asset Value(s)
9th Feb 20235:00 pmRNSComposition of Board Committee
7th Feb 20237:00 amRNSNet Asset Value(s)
21st Dec 202212:52 pmRNSDirector/PDMR Shareholding
21st Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20225:20 pmRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSNet Asset Value(s)
8th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSNet Asset Value(s)
14th Oct 20227:00 amRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
20th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSNet Asset Value(s)
7th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
17th Aug 20225:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.